Header graphic for print
The Healthcare Investor Insights on Issues & Trends that Impact Investments in Healthcare & Life Science Businesses

Healthcare & Life Sciences Private Equity Deal Tracker: Xlumena Closes $25 Million in Series C Financing

Posted in Healthcare Services Investing

Xlumena, Inc., has announced it has closed $25 million in Series C financing.

Xlumena, headquartered in Mountain View, Calif., is a developer of image-guided therapeutic endoscopy products.

The financing round included existing investors Prism VentureWorks, Charter Life Sciences, Ascent Biomedical Ventures and Aperture Venture Partners. 

Xlumena indicated it will use the proceeds to support efforts to expand global commercialization for its AXIOS family of devices and bring the platform to the U.S.

We use cookies to enhance your experience of our website. By continuing to use this website, you agree to the use of these cookies. For more information and to learn how you can change your cookie settings, please see our policy.